Ethical and clinical safety considerations in the design of an effectiveness trial: A comparison of buprenorphine versus naltrexone treatment for opioid dependence-Reference-Cited by-同舟云学术

Ethical and clinical safety considerations in the design of an effectiveness trial: A comparison of buprenorphine versus naltrexone treatment for opioid dependence

Published:2016-11 Issue: Volume:51 Page:34-43
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Nunes Edward V.,Lee Joshua D,Sisti Dominic,Segal Andrea,Caplan Arthur,Fishman Marc,Bailey Genie,Brigham Gregory,Novo Patricia,Farkas Sarah,Rotrosen John

Funder

National Institute on Drug Abuse Clinical Trials Network

NIDA

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference57 articles.

1. Bridging the Gap Between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment;Institute of Medicine,1998

2. Choosing a control group in effectiveness trials of behavioral drug abuse treatments;Brigham;J. Subst. Abus. Treat.,2009

3. Ten take home lessons from the first 10years of the CTN and 10 recommendations for the future;Carroll;Am J Drug Alcohol Abuse.,2011

4. Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs?;Nunes;J. Subst. Abus. Treat.,2010

5. The design and analysis of multisite effectiveness trials: a decade of progress in the National Drug Abuse Clinical Trials Network;Nunes;Am J Drug Alcohol Abuse.,2011

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Medication-Based Treatment on Health Care Utilization Among Individuals With Opioid Use Disorder;Psychiatric Services;2023-12-01

2. Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder;Journal of Addiction Medicine;2023-05-17

3. Optimally Choosing Medication Type for Patients With Opioid Use Disorder;American Journal of Epidemiology;2022-12-22

4. Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder;Drug and Alcohol Dependence Reports;2022-12

5. Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone;Substance Use & Misuse;2022-08-17